Citadel Advisors’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$811K Buy
20,649
+2,493
+14% +$97.9K ﹤0.01% 8150
2025
Q4
$659K Buy
+18,156
New +$681K ﹤0.01% 8345
2025
Q2
Sell
-35,313
Closed -$1.28M 12640
2025
Q1
$1.28M Sell
35,313
-665
-2% -$25.9K ﹤0.01% 6405
2024
Q4
$1.41M Buy
35,978
+3,314
+10% +$129K ﹤0.01% 6354
2024
Q3
$1.19M Sell
32,664
-846
-3% -$30.2K ﹤0.01% 6504
2024
Q2
$1.17M Buy
33,510
+3,176
+10% +$110K ﹤0.01% 6288
2024
Q1
$1.1M Sell
30,334
-1,381
-4% -$47.2K ﹤0.01% 6728
2023
Q4
$1.05M Buy
+31,715
New +$975K ﹤0.01% 6581
2023
Q2
Sell
-27,326
Closed -$851K 14367
2023
Q1
$851K Sell
27,326
-800
-3% -$24.4K ﹤0.01% 7144
2022
Q4
$832K Buy
28,126
+12,385
+79% +$372K ﹤0.01% 7165
2022
Q3
$442K Sell
15,741
-4,826
-23% -$150K ﹤0.01% 8732
2022
Q2
$620K Buy
20,567
+14,189
+222% +$487K ﹤0.01% 8169
2022
Q1
$242K Sell
6,378
-680
-10% -$24.9K ﹤0.01% 11079
2021
Q4
$273K Sell
7,058
-4,115
-37% -$152K ﹤0.01% 11117
2021
Q3
$383K Buy
+11,173
New +$386K ﹤0.01% 10515
2019
Q4
Sell
-13,710
Closed -$268K 9121
2019
Q3
$268K Buy
+13,710
New +$287K ﹤0.01% 7727
2019
Q2
Sell
-16,537
Closed -$333K 9180
2019
Q1
$333K Buy
16,537
+4,091
+33% +$79.1K ﹤0.01% 7457
2018
Q4
$216K Buy
+12,446
New +$250K ﹤0.01% 7747

Other funds holding BOUT

Citadel Advisors's BOUT Position: Q1 2026 in Review

Citadel Advisors increased its CapForce IBD Breakout Opportunities ETF (BOUT) stake by 14% in Q1 2026, buying an estimated $97.9K and bringing the position to 20,649 shares worth $811K. The position accounts for ﹤0.01% of the portfolio, ranked #8150.

Citadel Advisors first reported a position in BOUT in Q4 2018 and has held it in 18 quarters since. The position peaked at $1.41M in Q4 2024. 14 funds tracked by Wall St. Rank hold BOUT as of Q1 2026.

  • Citadel Advisors held 20,649 shares of CapForce IBD Breakout Opportunities ETF worth $811K as of Q1 2026.
  • Citadel Advisors bought 2,493 CapForce IBD Breakout Opportunities ETF shares in Q1 2026, an estimated $97.9K.
  • CapForce IBD Breakout Opportunities ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #8150 holding.
  • Citadel Advisors first reported a position in CapForce IBD Breakout Opportunities ETF in Q4 2018 and has held it in 18 quarters since.
  • Citadel Advisors's CapForce IBD Breakout Opportunities ETF position peaked at $1.41M in Q4 2024.
  • 14 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.